Sonoma Pharmaceuticals, Inc. (SNOA): Price and Financial Metrics
SNOA Price/Volume Stats
| Current price | $0.16 | 52-week high | $1.52 |
| Prev. close | $0.16 | 52-week low | $0.12 |
| Day low | $0.15 | Volume | 118,909 |
| Day high | $0.17 | Avg. volume | 1,638,100 |
| 50-day MA | $0.15 | Dividend yield | N/A |
| 200-day MA | $0.44 | Market Cap | 2.50M |
SNOA Stock Price Chart Interactive Chart >
Sonoma Pharmaceuticals, Inc. (SNOA) Company Bio
Sonoma Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company develops and markets solutions for the treatment of dermatological conditions and advanced tissue care. Sonoma Pharmaceuticals serves customers worldwide.
Latest SNOA News From Around the Web
Below are the latest news stories about SONOMA PHARMACEUTICALS INC that investors may wish to consider to help them evaluate SNOA as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayIt's time to dive into the biggest pre-market stock movers as we check out all of the hottest trading news for Tuesday morning! |
Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2024 Financial ResultsGross profit percentage of 36% for the quarter, up 1% from first fiscal quarter 2024Total operating expenses decreased for the quarter and six months ended September 30, 2023 compared to same period prior yearEuropean revenues increased 3% for the ... |
Sonoma Pharmaceuticals Announces U.S. Launch of Next Generation Advanced Solution for Pulse Lavage Irrigation at the Symposium on Advanced Wound Care Fall ConferenceBOULDER, CO / ACCESSWIRE / November 3, 2023 / Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, ... |
Sonoma Pharmaceuticals, Inc. Announces Pricing of $1.7 Million Public Offering of Common StockBOULDER, CO / ACCESSWIRE / October 26, 2023 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, ... |
Dawson James Securities Announces October Date for 8th Annual Small Cap Growth ConferenceJUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8th Annual Dawson James Small Cap Growth Conference on October 12, 2023, at the Wyndham Grand Hotel in Jupiter, FL. Dawson James’ flagship Small Cap Growth Conference brings together senior leadership from over 30 of the most innovative companies at the forefront of healthcare, technology and consu |
SNOA Price Returns
| 1-mo | 14.29% |
| 3-mo | -4.82% |
| 6-mo | -10.06% |
| 1-year | -84.16% |
| 3-year | -98.01% |
| 5-year | -97.94% |
| YTD | -11.31% |
| 2023 | -83.89% |
| 2022 | -75.44% |
| 2021 | -37.19% |
| 2020 | 66.51% |
| 2019 | -31.77% |
Continue Researching SNOA
Want to see what other sources are saying about Sonoma Pharmaceuticals Inc's financials and stock price? Try the links below:Sonoma Pharmaceuticals Inc (SNOA) Stock Price | Nasdaq
Sonoma Pharmaceuticals Inc (SNOA) Stock Quote, History and News - Yahoo Finance
Sonoma Pharmaceuticals Inc (SNOA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...